The FDA has approved fFN testing for use as an aid in assessing the risk for preterm birth in women with or without symptoms of preterm labor.

An easy, 4-step procedure for collecting specimens, including instructions for ensuring accurate patient results.

Essential reimbursement codes associated with fFN.

Information for laboratory technologists, including step-by-step instructions for using the TLi_IQ^® System to provide test results to healthcare providers.

The QuikCheck fFN test is not approved for sales and marketing in the U.S. or licensed for sale in Canada.

A simple, reliable test that determines the risk of preterm birth.